Table 2.
Baseline characteristics of hospitalized and ambulatory COVID-19 patients
| COVID-19 patient characteristic | Hospitalized (n = 18) | Ambulatory (n = 16) | P-value |
|---|---|---|---|
| Median age (range) | 69 (28–83) | 43 (18–63) | < 0.0001 |
| Male (n) (%) | 12 (63%) | 7 (44%) | NS |
| Median blood pressure (systolic/diastolic) | 135/74 | 143/92 | NS |
| Median respiratory rate (breaths/minute) (SD) | 20 (± 2.7) | 18 (± 3.1) | NS |
| Median heart rate (beats per minute) (SD) | 80 (± 9.8) | 71 (± 17.5) | NS |
| Geometric mean (range minimum. – maximum) | |||
| Leukocyte (n/µL) | 6,139 (3,230–12,300) | NA | – |
| Neutrophils (%) | 67 (36–82) | NA | – |
| Lymphocytes (%) | 19 (8–49) | NA | – |
| Monocytes (%) | 9 (2–14) | NA | – |
| Eosinophils (%) | 0 (0–4) | NA | – |
| Basophils (%) | 0.5 (0.1–1.3) | NA | – |
| Erythrocytes (million/µL) | 4 (3–6) | NA | – |
| Hematocrit (%) | 37 (28–47) | NA | – |
| Hb (g/dL) | 12.7 (8–16) | NA | – |
| Thrombocytes (1,000/µL) | 233 (105–572) | NA | – |
| Fibrinogen (mg/dL)* | 472 (211–768) | NA | – |
| Procalcitonin (ng/mL) | 0.09 (0.01–2.56) | NA | – |
| Creatine kinase (U/L) | 93 (19–2,468) | NA | – |
| AST (U/L) | 39 (17–748) | NA | – |
| ALT (U/L) | 31 (9–401) | NA | – |
| LDH (U/L) | 295 (153–899) | NA | – |
AST = aspartate Aminotransferase; ALT = alanine aminotransferase; LDH = lactate dehydrogenase; NA = not available; NS = nonsignificant as mild COVID-19 was observed in ambulatory patients without clinical complications.
*
Fibrinogen levels not available for one hospitalized patient.